Stanisic, Sanja, Americo Cicchetti, Camillo Porta, Giuseppe Procopio, and Patrizia Berto. “Cost-Effectiveness of Cabozantinib in Second-Line Treatment of Metastatic Renal Cell Cancer (mRCC) in Italy”. Global and Regional Health Technology Assessment 5, no. 1 (July 27, 2018). Accessed November 21, 2024. https://journals.aboutscience.eu/index.php/grhta/article/view/434.